Concepedia

Publication | Open Access

Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma

DOIFull Paper Access

13

Citations

24

References

2024

Year

Peter Thuss‐Patience, Anica Högner, Eray Goekkurt, M. Stahl, Albrecht Kretzschmar, Thorsten Oliver Götze, Gertraud Stocker, Peter Reichardt, Frank Kullmann, Daniel Pink,
JAMA Network Open

Abstract

ClinicalTrials.gov Identifier: NCT03966118.

References

YearCitations

Page 1